BCL2 and ovarian carcinoma: High expression of RBP LARP1 co-associates with BCL2 and BIK in BCL2 messenger ribonucleoprotein (mRNP) complexes in epithelial ovarian cancer and stabilizes BCL2 while destabilizing BIK, which promotes ovarian cancer cell survival and leads to adverse prognosis (Hopkins et al., 2016).